Skip to content

Clinical trials

Completed Carcinoma, Renal Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Completed Country / region: China Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20063
20072
20083
20103
20113
20131
20141
20151
20161
20171
20181
20192
20203
20213
20222
20234
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bayer3
GlaxoSmithKline3
RenJi Hospital3
Fuda Cancer Hospital, Guangzhou2
Peking Union Medical College Hospital2
Pfizer2
Sun Yat-sen University2
The Affiliated Hospital of Qingdao University2
Akeso1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell42
Kidney Neoplasms3
Adrenal Gland Neoplasms2
Neoplasm Metastasis2
Urinary Bladder Neoplasms2
Adenoma, Islet Cell1
Carcinogenesis1
Carcinoma1
Carcinoma, Transitional Cell1
Gastrointestinal Stromal Tumors1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.